M. Veillard
Impact in
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Advancements in Transdermal Drug Delivery
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
- biodegradable polymer synthesis and properties
Papers in
-
- Advanced Drug Delivery Systems 9
- Drug Solubulity and Delivery Systems 6
- Biomaterials 10
- Nanoparticle-Based Drug Delivery 8
- Co-authors
- G. Spenlehauer (12 shared papers)Didier Bazile (10 shared papers)Jean‐Pierre Benoît (2 shared papers)Patrick Couvreur (2 shared papers)Mark A. Longer (3 shared papers)Joseph R. Robinson (3 shared papers)Christine Vauthier (1 shared paper)Jean–Louis Grossiord (1 shared paper)
- Journals
- Journal of Controlled Release (5 papers)Journal of Pharmaceutical Sciences (2 papers)Biomaterials (2 papers)International Journal of Pharmaceutics (2 papers)Pharmaceutical Research (1 paper)
- Partner nations
- FranceUnited StatesGermany
In The Last Decade
M. Veillard
19 papers receiving 1.6k citations
M. Veillard's Hit Papers
Peers
Comparison fields: 5 of 108
- Pharmaceutical Science 733
- Biomaterials 981
- Surfaces, Coatings and Films 171
- Molecular Medicine 76
- Biomedical Engineering 359
Countries citing papers authored by M. Veillard
This map shows the geographic impact of M. Veillard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Veillard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Veillard more than expected).
Fields of papers citing papers by M. Veillard
This network shows the impact of papers produced by M. Veillard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Veillard. The network helps show where M. Veillard may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Veillard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Stealth Me. PEG‐PLA Nanoparticles Avoid Uptake by the Mononuclear Phagocytes System Hit paper breakdown → | 1995 | 510 |
| 2 | 2003 | 174 | |
| 3 | 1996 | 158 | |
| 4 | 1995 | 158 | |
| 5 | 1992 | 150 | |
| 6 | 1986 | 117 | |
| 7 | 1988 | 103 | |
| 8 | 1993 | 71 | |
| 9 | 1987 | 63 | |
| 10 | 1992 | 52 | |
| 11 | 1987 | 36 | |
| 12 | 1997 | 31 | |
| 13 | 1996 | 24 | |
| 14 | 1998 | 21 | |
| 15 | 1991 | 19 | |
| 16 | 1989 | 10 | |
| 17 | 1992 | 10 | |
| 18 | 1993 | 10 | |
| 19 | 1979 | 7 |
About M. Veillard
M. Veillard is a scholar working on Pharmaceutical Science, Biomaterials, Molecular Biology, Pulmonary and Respiratory Medicine and Nutrition and Dietetics, having authored 19 papers that have together received 1.7k indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (9 papers), Nanoparticle-Based Drug Delivery (8 papers), Drug Solubulity and Delivery Systems (6 papers), Analytical Methods in Pharmaceuticals (2 papers), Cancer Treatment and Pharmacology (2 papers), Biochemical Analysis and Sensing Techniques (2 papers), Biopolymer Synthesis and Applications (2 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). The work is most often cited by research in Pharmaceutical Science (733 citations), Biomaterials (981 citations), Surfaces, Coatings and Films (171 citations), Molecular Medicine (76 citations) and Biomedical Engineering (359 citations). M. Veillard has collaborated with scholars based in France, United States and Germany. Frequent co-authors include G. Spenlehauer, Didier Bazile, Jean‐Pierre Benoît, Patrick Couvreur, Mark A. Longer, Joseph R. Robinson, Christine Vauthier, Jean–Louis Grossiord, F. Puisieux and Denis Labarre. Their work appears in journals such as Journal of Controlled Release, Journal of Pharmaceutical Sciences, Biomaterials, International Journal of Pharmaceutics and Pharmaceutical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.